Skip to main content
. 2023 Jan 5;128(6):1030–1039. doi: 10.1038/s41416-022-02131-8

Fig. 2. Disease free survival and overall survival of patients with mDLC falls between what is observed for patients with IDC and ILC.

Fig. 2

Disease-free survival (a) and overall survival (b) of patients with ER-positive cases of mDLC, ILC, and IDC. The p values are calculated by log-rank test. The p values of pairwise comparison are adjusted by Bonferroni correction. Disease-free survival analysis is limited to patients with Stage I–III disease.